| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 5361733
[patent_doc_number] => 20090036527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'Therapeutic Application Of Leonurine In Treating Cardiomyopathy'
[patent_app_type] => utility
[patent_app_number] => 12/185052
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5999
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036527.pdf
[firstpage_image] =>[orig_patent_app_number] => 12185052
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/185052 | Therapeutic Application Of Leonurine In Treating Cardiomyopathy | Jul 31, 2008 | Abandoned |
Array
(
[id] => 5272274
[patent_doc_number] => 20090076050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'SYNERGISTIC TUMOR-KILLING EFFECT OF RADIATION AND BERBERINE COMBINED TREATMENT IN LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/184733
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4583
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076050.pdf
[firstpage_image] =>[orig_patent_app_number] => 12184733
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/184733 | SYNERGISTIC TUMOR-KILLING EFFECT OF RADIATION AND BERBERINE COMBINED TREATMENT IN LUNG CANCER | Jul 31, 2008 | Abandoned |
Array
(
[id] => 6196712
[patent_doc_number] => 20110028470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Detection and Treatment of Schizophrenia'
[patent_app_type] => utility
[patent_app_number] => 12/674018
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37648
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028470.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674018
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674018 | Detection and treatment of schizophrenia | Jul 30, 2008 | Issued |
Array
(
[id] => 6196712
[patent_doc_number] => 20110028470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Detection and Treatment of Schizophrenia'
[patent_app_type] => utility
[patent_app_number] => 12/674018
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37648
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028470.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674018
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674018 | Detection and treatment of schizophrenia | Jul 30, 2008 | Issued |
Array
(
[id] => 5522098
[patent_doc_number] => 20090030079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'USES OF TRIENTINE AND PENICILLAMINE AS COUNTERMEASURES TO METAL CONTAMINATION'
[patent_app_type] => utility
[patent_app_number] => 12/180130
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6403
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12180130
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/180130 | USES OF TRIENTINE AND PENICILLAMINE AS COUNTERMEASURES TO METAL CONTAMINATION | Jul 24, 2008 | Abandoned |
Array
(
[id] => 5522085
[patent_doc_number] => 20090030066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'SMALL MOLECULES FOR THE PROTECTION OF PANCREATIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/178282
[patent_app_country] => US
[patent_app_date] => 2008-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11668
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20090030066.pdf
[firstpage_image] =>[orig_patent_app_number] => 12178282
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/178282 | SMALL MOLECULES FOR THE PROTECTION OF PANCREATIC CELLS | Jul 22, 2008 | Abandoned |
Array
(
[id] => 6545896
[patent_doc_number] => 20100016329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'XANTHINE-BASED CYCLIC GMP-ENHANCING RHO-KINASE INHIBITOR INHIBITS PHYSIOLOGICAL ACTIVITIES OF LUNG EPITHELIAL CELL LINE'
[patent_app_type] => utility
[patent_app_number] => 12/176607
[patent_app_country] => US
[patent_app_date] => 2008-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 6671
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016329.pdf
[firstpage_image] =>[orig_patent_app_number] => 12176607
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/176607 | XANTHINE-BASED CYCLIC GMP-ENHANCING RHO-KINASE INHIBITOR INHIBITS PHYSIOLOGICAL ACTIVITIES OF LUNG EPITHELIAL CELL LINE | Jul 20, 2008 | Abandoned |
Array
(
[id] => 6007977
[patent_doc_number] => 20110060008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCHOLINE ESTERASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/666508
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4781
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20110060008.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666508 | PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCHOLINE ESTERASE INHIBITOR AND METHOD FOR THE PREPARATION THEREOF | Jun 25, 2008 | Abandoned |
Array
(
[id] => 5297246
[patent_doc_number] => 20090012172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith'
[patent_app_type] => utility
[patent_app_number] => 12/213153
[patent_app_country] => US
[patent_app_date] => 2008-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3814
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012172.pdf
[firstpage_image] =>[orig_patent_app_number] => 12213153
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/213153 | Cosmetic/pharmaceutical compositions comprising retinoids and anti-irritants and treatment of keratinization disorders therewith | Jun 15, 2008 | Abandoned |
Array
(
[id] => 6639005
[patent_doc_number] => 20100173990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Transglutaminase Inhibitor Comprising Chlorogenic Acid And A Method For Producing Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/663348
[patent_app_country] => US
[patent_app_date] => 2008-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4106
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173990.pdf
[firstpage_image] =>[orig_patent_app_number] => 12663348
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663348 | Transglutaminase Inhibitor Comprising Chlorogenic Acid And A Method For Producing Thereof | Jun 10, 2008 | Abandoned |
Array
(
[id] => 4682958
[patent_doc_number] => 20080249184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Methods for modulating neuronal cell death'
[patent_app_type] => utility
[patent_app_number] => 12/157284
[patent_app_country] => US
[patent_app_date] => 2008-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13358
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249184.pdf
[firstpage_image] =>[orig_patent_app_number] => 12157284
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/157284 | Methods for modulating neuronal cell death | Jun 8, 2008 | Abandoned |
Array
(
[id] => 7683737
[patent_doc_number] => 20100240674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'USE OF COMPOUNDS DERIVED FROM BENZAMIDINE METHANESULPHONATE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR EXAMPLE IMATINIB MESYLATE, FOR THE PREPARATION O F A DRUG FOR THE TREATMENT OF NEURODEGENERATIVE NIEMANN-PICK C DISEASE (NPC)'
[patent_app_type] => utility
[patent_app_number] => 12/602447
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4908
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602447 | USE OF COMPOUNDS DERIVED FROM BENZAMIDINE METHANESULPHONATE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR EXAMPLE IMATINIB MESYLATE, FOR THE PREPARATION O F A DRUG FOR THE TREATMENT OF NEURODEGENERATIVE NIEMANN-PICK C DISEASE (NPC) | May 27, 2008 | Abandoned |
Array
(
[id] => 6320319
[patent_doc_number] => 20100196342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'MOOD, MEMORY AND COGNITIVE FUNCTION WITH PYRIDOXAL 5\'-PHOSPHATE'
[patent_app_type] => utility
[patent_app_number] => 12/602435
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2509
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196342.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602435
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602435 | MOOD, MEMORY AND COGNITIVE FUNCTION WITH PYRIDOXAL 5'-PHOSPHATE | May 27, 2008 | Abandoned |
Array
(
[id] => 7650873
[patent_doc_number] => 20110300142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS'
[patent_app_type] => utility
[patent_app_number] => 12/601021
[patent_app_country] => US
[patent_app_date] => 2008-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7235
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12601021
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601021 | USE OF ZEBURALINE FOR THE TREATMENT OF AUTOIMMUNE DISEASES OR IMMUNE REJECTION OF TRANSPLANTS | May 25, 2008 | Abandoned |
Array
(
[id] => 6432817
[patent_doc_number] => 20100152244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 12/600689
[patent_app_country] => US
[patent_app_date] => 2008-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2079
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152244.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600689
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600689 | SELF-EMULSIFYING FORMULATION OF TIPRANAVIR FOR ORAL ADMINISTRATION | May 20, 2008 | Abandoned |
Array
(
[id] => 4950017
[patent_doc_number] => 20080306143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Cathechins for the Treatment of Fibrillogenesis in Alzheimer\'s Disease, Parkinson\'s Disease, Systemic AA Amyloidosis, and Other Amyloid Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/119416
[patent_app_country] => US
[patent_app_date] => 2008-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26652
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306143.pdf
[firstpage_image] =>[orig_patent_app_number] => 12119416
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/119416 | Cathechins for the Treatment of Fibrillogenesis in Alzheimer's Disease, Parkinson's Disease, Systemic AA Amyloidosis, and Other Amyloid Disorders | May 11, 2008 | Abandoned |
Array
(
[id] => 4456363
[patent_doc_number] => 07893083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Method of treating genital herpes'
[patent_app_type] => utility
[patent_app_number] => 12/113833
[patent_app_country] => US
[patent_app_date] => 2008-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 7119
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/893/07893083.pdf
[firstpage_image] =>[orig_patent_app_number] => 12113833
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/113833 | Method of treating genital herpes | Apr 30, 2008 | Issued |
Array
(
[id] => 8592019
[patent_doc_number] => 08349895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Products containing highly unsaturated fatty acids for use by women during stages of preconception, pregnancy and lactation/post-partum'
[patent_app_type] => utility
[patent_app_number] => 12/111844
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6508
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 328
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12111844
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/111844 | Products containing highly unsaturated fatty acids for use by women during stages of preconception, pregnancy and lactation/post-partum | Apr 28, 2008 | Issued |
Array
(
[id] => 7687543
[patent_doc_number] => 20090176748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'METHODS AND COMPOSITIONS FOR CONTROLLED RELEASE ORAL DOSAGE OF A VITAMIN D COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/109983
[patent_app_country] => US
[patent_app_date] => 2008-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16665
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176748.pdf
[firstpage_image] =>[orig_patent_app_number] => 12109983
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/109983 | Methods and compositions for controlled release oral dosage of a vitamin D compound | Apr 24, 2008 | Issued |
Array
(
[id] => 5458743
[patent_doc_number] => 20090258895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'PHARMACEUTICAL FORMULATION AND PROCESS COMPRISING A SOLID DISPERSION OF MACROLIDE (TACROLIMUS)'
[patent_app_type] => utility
[patent_app_number] => 12/101500
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3392
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258895.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101500
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101500 | Pharmaceutical formulation and process comprising a solid dispersion of macrolide (tacrolimus) | Apr 10, 2008 | Issued |